Literature DB >> 70354

Macroamylasaemia after treatment with hydroxyethyl starch.

H Köhler, W Kirch, T R Weihrauch, W Prellwitz, H J Horstmann.   

Abstract

After infusion of 500 ml of 6% hydroxyethyl starch into fifty-four patients an increase of serum amylase was observed which in fifty-one cases exceeded the upper limit of normal (190 U/l). In most cases serum amylase reached twice the basal value. Renal function influenced the duration of the increase in serum amylase, but not the maximum increase (201+/-15 U/l; mean+/-SEM). In patients with advanced renal failure (glomerular filtration rate (GFR) = 2-10 ml/min) serum amylase was still markedly elevated after 72 h (298+/-24 U/l; mean+/-SEM). In patients with normal renal function (GFR greater than 90 ml/min) serum amylase decreased to 183+/-40 U/l (mean+/-SEM) within 72 h without reaching basal values. After infusion of HES no changes were observed in serum lipase or in amylase or lipase activities in duodenal secretion. Amylase excretion in the urine decreased. The assumption of a macroamylasaemia caused by formation of an HES-amylase complex was confirmed by gel filtration. The elimination from plasma of this high molecular enzyme-substrate complex is slow and causes hyperamylasaemia. In no case was the macroamylasaemia associated with signs or symptoms. An awareness of this causal relationship seems to be important, to avoid the erroneous diagnosis of a pancreatic disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70354     DOI: 10.1111/j.1365-2362.1977.tb01599.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].

Authors:  H Köhler; W Kirch; H Pitz
Journal:  Klin Wochenschr       Date:  1978-10-01

2.  [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].

Authors:  H Köhler; H Zschiedrich; A Linfante; F Appel; H Pitz; R Clasen
Journal:  Klin Wochenschr       Date:  1982-03

3.  Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%).

Authors:  A C Degrémont; M Ismaïl; M Arthaud; B Oulare; O Mundler; M Paris; J F Baron
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 4.  Macroamylasemia and other immunoglobulin-complexed enzyme disorders.

Authors:  D C Klonoff
Journal:  West J Med       Date:  1980-11

5.  Protein contents and binding modes of immunoglobulin-amylase complexes.

Authors:  H Ohtani; K Sakaguchi; M Saito
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

6.  Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers.

Authors:  J Waitzinger; F Bepperling; G Pabst; J Opitz; M Müller; J François Baron
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.